| Product NDC: | 43386-620 |
| Proprietary Name: | My Way |
| Non Proprietary Name: | Levonorgestrel |
| Active Ingredient(s): | 1.5 mg/1 & nbsp; Levonorgestrel |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43386-620 |
| Labeler Name: | GAVIS Pharmaceuticals, LLC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202508 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130222 |
| Package NDC: | 43386-620-30 |
| Package Description: | 1 TABLET in 1 CARTON (43386-620-30) |
| NDC Code | 43386-620-30 |
| Proprietary Name | My Way |
| Package Description | 1 TABLET in 1 CARTON (43386-620-30) |
| Product NDC | 43386-620 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levonorgestrel |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130222 |
| Marketing Category Name | ANDA |
| Labeler Name | GAVIS Pharmaceuticals, LLC. |
| Substance Name | LEVONORGESTREL |
| Strength Number | 1.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC] |